Donnerstag, 27.03.2025

11:45 - 13:15

Hörsaal 2

S1

Progression und Prognose bei Glomerulonephrits

Moderation: B. Tönshoff, Heidelberg; M. Hansen, Frankfurt a. M.

11:45
Outcome and Prognostic Factors in Pediatric IgA Nephropathy
 

L. Antonucci, Rom/I

12:15
IgA Nephropathie - Paradigmenwechsel in der Therapie?
 

J. Floege, Aachen

12:45
Prevention of human papillomavirus (HPV) infection in pediatric kidney (KTx) and liver transplant recipients (LTx) and in pediatric patients with advanced chronic kidney disease (CKD): a prospective, multicenter vaccine surveillance trial (HPVaxResponse study)
FV01 

B. Höcker, K. M. Krupka, T. Waterboer, J. Butt, B. Tönshoff; Heidelberg

12:55
Thrombospondin-1 (TSP-1) as a Complement Regulator in ANCA-Associated Vasculitis
FV02 

S. Konwar, S. Schroda, J. Kleindienst, E. Decker, M. Pohl, B. Zieger, J. Panse, H. Wang, R. Grosse, M. Rogg, C. Schell, S. Vidal, X. Liu, C. Gorzelanny, T. Tschongov, K. Häffner; Freiburg, Aachen, Hamburg

13:05
VALIANT: Randomized, multicenter, double-blind, placebo controlled, phase 3 trial of pegcetacoplan for patients with native or post-transplant recurrent C3G or primary IC-MPGN
FV03 

C. Nester, A. Bomback, M. A. G. A. Iraola, Y. Delmas, B. P. Dixon, D. Gale, L. Greenbaum, S. H. Han, N. Isbel, C. Licht, A. Mastrangelo, M. Mizuno, M. I. Neves de Holanda, M. C. Pickering, G. Remuzzi, N. van de Kar, M. Vivarelli, P. Walker, D. Wallace, D. Zecher, L. Li, Z. Wang, L. López Lázaro, J. Szamosi, F. Fakhouri; Iowa City/USA, New York/USA, Barcelona/E, Bordeaux/F, Aurora/USA, London/UK, Atlanta/USA, Seoul/ROK, Brisbane/AUS, Toronto/CDN, Milano/I, Nagoya/J, Rio de Janeiro/BRA, Milan/I, Nijmegen/NL, Rome/I, Little Rock/USA, Manchester/UK, Regensburg, Waltham/USA, Stockholm/S, Lausanne/CH

Zurück